May 16, 2017
Posted May 30, 2017
Omnicare Inc. agreed to pay $8 million to settle charges it violated the False Claims Act by submitting claims for generic drugs different from those actually dispensed to Medicare and Medicaid beneficiaries. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Elizabeth Corsi and Christopher Ezzie. They will receive a whistleblower award of more than $2 million from the proceeds of the government’s recovery. DOJ (DNJ)
Tagged in: Drug Switching, Medicare, SNF, Whistleblower Case, Whistleblower Rewards,